Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 04/2020
previous issue
This is a translation of the table of contents. One article is translated and freely available.

NEW ON THE MARKET
Semaglutide (OZEMPIC) and other GLP-1 agonists in type 2 diabetes
Romosozumab (EVENITY) for postmenopausal osteoporosis

THERAPY FROM A CRITICAL VIEWPOINT
ISCHEMIA trial: invasive or conservative treatment in stable coronary artery disease? (short version)

IN BRIEF
Varicella-zoster virus reactivation after vaccination with SHINGRIX?  free article 
Ranitidine (e.g. RANITIC) withdrawn from the market in the USA
Ingenol mebutate (PICATO): approval withdrawn

CURRENT ADR NETWORK REPORT
Pruritus with new oral anticoagulants

SIDE EFFECTS
Severe liver damage with pirfenidone (ESBRIET)
Fluorouracil cytostatics screen for enzyme deficiency

e a-t ON THE INTERNET
Relocate production of drugs back to Germany and Europe respectively?
Chloroquine and hydroxychloroquine in COVID-19?
ISCHEMIA trial: invasive or conservative treatment in stable coronary artery disease? (long version)
© 2020 arznei-telegramm